All Clinical Trials
Below is a list of all clinical trials, conducted by several of our specialty service lines. You may filter the list of trials by clicking the "Department" dropdown menu and selecting the area that you want to view or that pertains to you.
Clicking "Learn More" may either take you to more information about our departments that conduct the research, or to the official clinicaltrials.gov page for more information about the trial.
A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined with Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Ca
INTEGRATED CANCER REPOSITORY FOR CANCER RESEARCH (iCaRe2)
Head and Neck, Brain, Breast Cancer, Hematologic Cancer, GI, GU, Melanoma, Gynecologic Cancer, Lung Cancer
NRG-CC014, Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT) (NCT06745024)
Study # NRG-CC014 Date Opened: 06/09/2025 Closing Date: 10/01/2028 Principal Investigator: Jason T. Shumadine, M.D. Sponsor: NRG Oncology
